Wells Fargo has maintained its 'Equal-Weight' rating on Baxter International but increased its price target from $23 to $25. This adjustment suggests a modest potential upside of 6.4% from the stock's recent closing price, indicating a slightly more positive outlook from the analyst.
Wells Fargo reaffirmed its 'Equal-Weight' rating for Baxter International Inc. while raising its price target from $23 to $25. This 8.7% increase in the target price implies a potential upside of approximately 6.4% from the stock's closing price on October 29, 2026. This analyst action signals a slightly improved outlook for Baxter, potentially attracting some investor interest due to the higher price target. For traders, this could lead to short-term positive sentiment, though the 'Equal-Weight' rating suggests no strong conviction for outperformance. The key opportunity lies in potential short-term price appreciation if the market reacts positively to the revised target, but the overall neutral rating limits long-term bullish implications.